EDGC to provide early cancer detection services to Europe working with Ukraine-based clinic
Posted : 2021-01-28 17:59
Updated : 2021-01-28 17:59
EDGC s co-CEO Lee Min-seob, second from left, speaks at the 2019 Kyiv International Economic Forum in Kiev, Ukraine. Courtesy of EDGC
By Ko Dong-hwan
South Korean genome research company Eone Diagnomics Genome Center (EDGC) said it will start providing early cancer detection services to Europe working with a Ukraine-based clinic that is participating in its research.
Working with PB MEDICOM-IN, based in Dnipro, the Ukraine, EDGC will for the first time in Europe provide two types of liquid biopsy services for cancer diagnosis, according to EDGC, Jan. 26. The two companies have conducted clinical trials for the services for about a year.